The FDA approved Eli Lily drug Mounjaro as a treatment for type 2 diabetes. The decision gives the pharmaceutical giant a new competitor to a blockbuster drug from rival Novo Nordisk, as well as a successor to its blockbuster diabetes drug Trulicity.
Pairing rheumatology expertise with the latest digital technologies, this app helps patients manage their treatment regimen with innovative and intuitive features.
Government-funded initiatives such as the Cancer Moonshot support not only the primary science that often serves as a foundation for medical advances, but also ensure that patients with rare cancers are not overlooked.
One way MA plans can stand out in an increasingly competitive market is by making members aware of the benefits they may not even know they have and encouraging them to use those benefits.
This event will bring together healthcare futurists, novel employers, payers, providers, and forward-thinking investors and entrepreneurs who support the broad transformation being spearheaded by digital health technologies.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments